Related Experiment Video
Updated: Apr 30, 2026
07:59
Transition of Farm Pigs to Research Pigs using a Designated Checklist followed by Initiation of Clicker Training - a Refinement Initiative
Published on: August 21, 2021
5.2K
Innovation in animal health under Regulation (EU) 2019/6: Review and recommendations
Klaus Hellmann1, Helen Jukes1, Matthias Hofer2
1Klifovet GmbH, Munich, Germany.
Frontiers in Veterinary Science
|April 29, 2026
Summary
The EU Veterinary Medicinal Products Regulation (VMPR) impacts animal health innovation, presenting challenges and proposing adaptations for VMPs. Strategic actions are needed to foster novel therapies and sustainability in limited markets.
Area of Science:
- Veterinary Medicine
- Regulatory Science
- Animal Health Innovation
Background:
- The EU Veterinary Medicinal Products Regulation (EU) 2019/6 aims to harmonize veterinary medicinal products across the EU.
- Innovation in animal health is crucial for public health, animal welfare, and sustainable agriculture.
- Stakeholders face significant hurdles in developing and registering new veterinary medicinal products.
Purpose of the Study:
- To evaluate the impact of the EU VMPR on innovation within the animal health sector.
- To identify regulatory, scientific, and commercial challenges affecting VMP development.
- To propose strategic actions for fostering innovation in veterinary medicine.
Main Methods:
- Synthesis of outcomes from an interdisciplinary conference.
- Analysis of expert presentations and panel discussions.
- Review of current regulatory, scientific, and commercial landscapes.
Main Results:
- The EU VMPR presents multifaceted challenges to innovation in animal health.
- Limited markets, novel therapies, and sustainability concerns are key areas of impact.
- Adaptations in regulation and procedures are necessary to support VMP development.
Conclusions:
- The current regulatory framework requires adjustments to effectively support innovation in veterinary medicinal products.
- Strategic interventions are essential to overcome challenges and promote the availability of novel VMPs.
- Fostering innovation is critical for advancing animal health and addressing future needs.
Related Concept Videos
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
369
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
369
01:25Clinical Significance of Antibiotic Resistance
90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
706
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706